Archive | January 2014

Portfolio, January 10, 2014 (featuring a trade!)

S&P 500:                 1842 (131.1%)

Portfolio:         $771,287 (154.3%)

IBB                    1153 shares    $274,356

FSAVX             sold

IAI                     5675 shares     $219,004

PGJ                   7750 shares    $237,522

Cash                                            $40,405

Notes: The portfolio has made its first trade in months, as FSAVX has not performed as well as top funds/ETFs in recent months.  The portfolio has done well even since the January 2 update, in large part due to its biotech stake.

 

Stocks? Pt. 4

Through the last year, the S&P 500 is up from 1462 to 1832 (25.3%), while the Morningstar value portfolio is up 21.2%.

Of the stocks in the original portfolio, Facebook nearly doubled (99%), Amazon was up by 55%, and Applied Materials was up 50%.  Other significant gainers included Microsoft, John Wiley General Dynamics, Amgen, and Bank of New York.   Unfortunately, Potash lost 21%, and Weight Watchers lost 40% over the same period.

The portfolio as a whole slightly underperformed the S&P 500 in a relative bull market, suggesting that blindly purchasing a portfolio of stocks meeting Morningstar’s value criteria may not be an optimal investment strategy, at least in the bull market of the past year.

Portfolio, January 1, 2014

S&P 500:                 1832 (130.36%)

Portfolio:         $751,762 (150.3%)

IBB                    1153 shares    $261,823

FSAVX             3820 shares    $212,850

PGJ                   7750 shares    $236,607

Cash                                           $40,480

Notes: The portfolio has not made any changes since the October 1 update, and has outperformed the S&P 500 by 66% since beginning this blog.  The portfolio lagged the S&P 500 in October, but outperformed in November and December, as reflected in the chart below:

chart114